Indeglitazar
CAS: 835619-41-5
Ref. 3D-KIB61941
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
Indeglitazar
Beschreibung:
Indeglitazar is a drug that belongs to the class of peroxisome proliferator-activated receptor (PPAR) agonists. It is used in the treatment of type 2 diabetes mellitus and has been shown to increase insulin sensitivity and lower blood pressure in animals. The mechanism of action is not fully understood, but it has been shown to inhibit oxidative DNA damage. Indeglitazar also increases peroxisomal beta-oxidation, which may be due to its inhibition of protein synthesis. This drug also inhibits protein synthesis by binding to dinucleotide phosphate (DNP), an intermediate in the synthesis of nucleic acids from nucleotides. Indeglitazar binds to DNP with a high affinity, preventing the formation of ATP and thereby inhibiting cell growth.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
389.42 g/mol
Formel:
C19H19NO6S
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
